logo
English (United Kingdom)Ukrainian (UA)
RESEARCH Protein Kinase Inhibitors CK2 Inhibitors 4-aminothieno[2,3-d]pyrimidines

4-aminothieno[2,3-d]pyrimidines

Novel CK2 inhibitors among 4-aminothieno[2,3-d]pyrimidines have been identified. The most active compounds obtained in the course of the research are 3-(5-p-tolyl-thieno[2,3-d]pyrimidin-4-ylamino)benzoic acid, 5e (NHTP23, IC50 = 0.01 mM), 3-(5-phenyl-thieno[2,3-d]pyrimidin-4-ylamino)-benzoic acid, 5g (NHTP25, IC50 = 0.065 mM) and 3-(6-methyl-5-phenyl-thieno[2,3-d]pyrimidin-4-ylamino)-bezoic acid, 5n (NHTP33, IC50 = 0.008 mM). The binding mode for compounds in this class with ATP-binding site of CK2 has been proposed (Fig. 1). 

CK2_nhtp
Figure 1. The binding mode of compound NHTP33 in the CK2 active site. Hydrogen bonds are shown by the dotted lines.


  • Design and synthesis of novel protein kinase CK2 inhibitors on the base of 4-aminothieno[2,3-d]pyrimidines. Ostrynska OV, Balanda AO, Bdzhola VG, Golub AG, Kotey IM, Kukharenko OP, Gryshchenko AA, Briukhovetska NV, Yarmoluk SM. Eur J Med Chem. 2016, 115: 148-160.

Other kinase inhibitors research:

CK2 Inhibitors
2-aminopyrimidinones and their 6-aza-analogs Image
In order to find the new potent CK2 inhibitors 60 derivatives of...



 

FGFR1 Inhibitors
Oxindoles Image
Oxindoles are known class of inhibitors of RTK, including FGFR1. We perform...



 

ASK1 Inhibitors
Evaluation of 2-Thioxo-thiazolidin-4-ones Derivatives as Inhibitors of ASK1 Image
In order to discover novel ASK1 inhibitors we have performed screening program,...



 

© 2012 All rights reserved
footer logo